KAY CHRISTINA has filed 6 insider transactions across 1 company since November 2024.
Most recent transaction: a grant/award of 140000 shares of INTEGRATED BIOPHARMA INC ($INBP) on December 09, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | INTEGRATED BIOPHARMA INC | $INBP | KAY CHRISTINA | Co-Chief Executive Officer | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 31,421,338 | 9999.99% | 0.45% |
| May 21, 2025 | INTEGRATED BIOPHARMA INC | $INBP | KAY CHRISTINA | Co-Chief Executive Officer | A | Common Stock | 144445 | $0.09 | 1,473,467.0000 | 31,303,011 | 10.87% | 0.46% |
| May 21, 2025 | INTEGRATED BIOPHARMA INC | $INBP | KAY CHRISTINA | Co-Chief Executive Officer | D | Stock Option (right to buy) | 144445 | $0.00 | 0.0000 | 31,303,011 | 100.00% | 0.46% |
| Dec. 4, 2024 | INTEGRATED BIOPHARMA INC | $INBP | KAY CHRISTINA | Co-Chief Executive Officer | A | Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 30,649,977 | 9999.99% | 0.41% |
| Nov. 25, 2024 | INTEGRATED BIOPHARMA INC | $INBP | KAY CHRISTINA | Co-Chief Executive Officer | A | Common Stock | 55555 | $0.09 | 1,329,022.0000 | 30,649,977 | 4.36% | 0.18% |
| Nov. 25, 2024 | INTEGRATED BIOPHARMA INC | $INBP | KAY CHRISTINA | Co-Chief Executive Officer | D | Stock Option (right to buy) | 55555 | $0.00 | 144,445.0000 | 30,649,977 | 27.78% | 0.18% |